MAXHEALTH Financial Statements

MAXHEALTH Nine Monthly Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2019 Mar-2018
Growth matrix (%)        
Revenue growth 32.90 11.40 (2.20) 7.52
Op profit growth 39.70 86.30 37 (19)
EBIT growth 42.50 121 50.40 (16)
Net profit growth (244) (3,267) (88) (259)
Profitability ratios (%)        
OPM 16.10 15.30 9.18 6.55
EBIT margin 13.80 12.80 6.48 4.21
Net profit margin (5.50) 5.06 (0.20) (1.50)
RoCE 6.41 8.16 4.48 3.05
RoNW (0.80) 1.36 (0.10) (0.50)
RoA (0.60) 0.80 -- (0.30)
Per share ratios ()        
EPS (1.20) 0.24 -- (0.50)
Dividend per share -- -- -- --
Cash EPS (3.20) (0.50) (2) (2.20)
Book value per share 58.40 47.50 17.90 21.70
Valuation ratios        
P/E (173) -- -- --
P/CEPS (64) -- -- --
P/B 3.53 -- -- --
EV/EBIDTA 39.20 -- -- --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (28) 7.03 (102) 37.60
Liquidity ratios        
Debtor days 33.70 44.40 69.30 54.30
Inventory days 5.87 5.11 5.86 5.42
Creditor days (56) (57) (73) (60)
Leverage ratios        
Interest coverage (1.90) (1.60) (1.10) (0.70)
Net debt / equity 0.08 0.30 1.03 0.77
Net debt / op. profit 1.11 2.61 6.39 7.86
Cost breakup ()        
Material costs (23) (21) (22) (25)
Employee costs (24) (24) (26) (24)
Other costs (37) (40) (43) (44)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Revenue 2,505 1,884 1,691 1,729
yoy growth (%) 32.90 11.40 (2.20) 7.52
Raw materials (581) (392) (364) (426)
As % of sales 23.20 20.80 21.60 24.60
Employee costs (589) (449) (441) (423)
As % of sales 23.50 23.80 26.10 24.50
Other costs (932) (754) (731) (767)
As % of sales 37.20 40 43.20 44.40
Operating profit 404 289 155 113
OPM 16.10 15.30 9.18 6.55
Depreciation (174) (120) (103) (94)
Interest expense (179) (153) (101) (99)
Other income 115 72.40 57.10 54.10
Profit before tax 165 89.10 8.32 (26)
Taxes (46) 6.26 (8.50) (10)
Tax rate (28) 7.03 (102) 37.60
Minorities and other (23) -- (2.80) 11.30
Adj. profit 96.20 95.30 (3) (25)
Exceptional items (234) -- -- --
Net profit (138) 95.30 (3) (25)
yoy growth (%) (244) (3,267) (88) (259)
NPM (5.50) 5.06 (0.20) (1.50)
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Profit before tax 165 89.10 8.32 (26)
Depreciation (174) (120) (103) (94)
Tax paid (46) 6.26 (8.50) (10)
Working capital 389 455 (651) --
Other operating items -- -- -- --
Operating cashflow 334 431 (753) (131)
Capital expenditure 6,049 (1,104) 135 --
Free cash flow 6,382 (674) (619) (131)
Equity raised 5,630 2,519 1,084 1,278
Investments (142) 2,182 0.51 --
Debt financing/disposal 682 122 130 5.60
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 12,552 4,150 596 1,153
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 966 537 537 537
Preference capital -- -- -- --
Reserves 4,673 2,016 426 627
Net worth 5,639 2,553 963 1,164
Minority interest
Debt 1,101 875 1,003 981
Deferred tax liabilities (net) 582 -- 529 383
Total liabilities 7,322 3,428 2,495 2,394
Fixed assets 6,563 879 2,279 2,265
Intangible assets
Investments 0.51 2,182 0.51 --
Deferred tax asset (net) 0.98 -- 195 52.20
Net working capital 104 248 8.05 (13)
Inventories 53.80 26.80 26 28.30
Inventory Days 7.84 5.19 5.61 5.97
Sundry debtors 366 96.10 363 280
Debtor days 53.30 18.60 78.30 59
Other current assets 907 671 674 638
Sundry creditors (463) (182) (319) (295)
Creditor days 67.40 35.30 68.90 62.40
Other current liabilities (760) (363) (736) (664)
Cash 653 120 11.60 90
Total assets 7,322 3,428 2,495 2,394
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Dec-2021 Dec-2020 Dec-2019 - -
Gross Sales 2,993 1,703 811 -- --
Excise Duty -- -- -- -- --
Net Sales 2,993 1,703 811 -- --
Other Operating Income -- -- -- -- --
Other Income 103 86.50 21 -- --
Total Income 3,095 1,789 832 -- --
Total Expenditure ** 2,269 1,701 737 -- --
PBIDT 826 88.20 94.90 -- --
Interest 78.70 135 58 -- --
PBDT 747 (47) 36.90 -- --
Depreciation 163 127 33.90 -- --
Minority Interest Before NP -- -- -- -- --
Tax 85.30 0.70 -- -- --
Deferred Tax 17.90 10.40 (0.10) -- --
Reported Profit After Tax 481 (184) 3.12 -- --
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 481 (207) 5.84 -- --
Extra-ordinary Items (7.40) (223) -- -- --
Adjusted Profit After Extra-ordinary item 489 15.40 5.84 -- --
EPS (Unit Curr.) 4.98 (2.50) 0.10 -- --
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 905 905 537 -- --
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 27.60 5.18 11.70 -- --
PBDTM(%) 25 (2.70) 4.55 -- --
PATM(%) 16.10 (11) 0.38 -- --
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity